Agreed Shatts, that's 1 major national rollout deal we already know is en route of what's expected to be many fresh valuation driving catalysts all already lined up and ready to roll directly on the heels of the incredible Rotmans foundational leverage directly ahead!
And Dr. Matthan and his attorneys didn't green light all the things outlined in the recent VYST/Vytex/Dr. Matthan PR without fully vetting every single thing stated in that news...so we can also expect Dr. Matthan to be playing a significant part in transitioning final stage R&D trials into full fledged commercialization endeavors soon too...otherwise that specific contracted task would not have been outlined in the news right!
And clearly VYST also has a multitude of burgeoning FEC commercialization opportunities heading down the pike in the post Rotmans era as well.
So our long patient wait to real action/real tangible results is about to officially be over the moment they announce the Rotmans acquisition and file the subsequent Definitive Acquisition Agreement 8K with the SEC within 72 hours of the Rotmans news!
And I also remain adamant that brand new investment banking partners are gonna be coming onboard directly on the heels of Rotmans too...as last weeks NYC meetings with institutional funders wasn't timed for last week by accident...there was good reason VYST was presenting in NYC last week this close to the official Rotmans final key foundational building block news finally arriving right cheers!
News 
Market Data 
Discover 
